Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma.
about
Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouseAdvances in the study of HLA-restricted epitope vaccines.Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinomaTumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.Cancer genome sequencing and its implications for personalized cancer vaccines.Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors.Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinomaHepatitis B core-based virus-like particles to present heterologous epitopes.The application of virus-like particles as vaccines and biological vehicles.Virus-based nanoparticles as platform technologies for modern vaccines.Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis.The immunogenicity of a novel cytotoxic T lymphocyte epitope from tumor antigen PL2L60 could be enhanced by 4-chlorophenylalanine substitution at position 1.Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma.Identification of a novel CD8+ T cell epitope derived from cancer-testis antigen MAGE-4 in oesophageal carcinoma.Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer.Cell-permeable capsids as universal antigen carrier for the induction of an antigen-specific CD8+ T-cell response.Designing string-of-beads vaccines with optimal spacers.Novel epitopes identified from efflux pumps of Mycobacterium tuberculosis could induce cytotoxic T lymphocyte response.Virus like particles as a platform for cancer vaccine development.Mechanisms for enhanced antitumor immune responses induced by irradiated hepatocellular carcinoma cells engineered to express hepatitis B virus X protein.
P2860
Q34043293-6CBFBFFD-0E68-4588-B295-B5454AA35A42Q34170130-17E5BFF9-C806-4E33-862B-0028CAE62D4CQ35091441-531048EB-27BE-4F95-BAF0-A9A2144D8480Q35894880-913F381F-61FF-445A-8662-5DA247015678Q37148184-8E011408-EC90-4ED3-B197-4C5686791031Q37367418-E424DF60-D0D7-414E-B3F3-296946565522Q37731958-872DC91C-0384-4B89-970D-52966696E4E9Q38081969-592C0DF7-D374-43CD-9B30-0869BE82EC1EQ38603912-93EBF355-41BF-474A-9BB7-8A1BF9F03E6DQ38702017-EAFB8380-8295-423A-96DA-A5E9B3F3FFB9Q39036942-4C378C00-0C50-40CA-AB73-8661CDAB4065Q39090059-B82F7217-7BE1-4CDA-AD2F-F1E7AA5EC833Q39472154-FDF327DA-1436-4EDA-9A78-E3D6F797D068Q39495212-DF5E955B-A9C7-4708-9365-ED75409E4A8CQ39516809-6499B845-9BA6-43EC-8B03-78255BD304A5Q40066002-B35F7DEB-5414-4801-A323-D3670A7F28B9Q41874594-958C9967-6CA8-4090-8DC2-C2BFA05146E7Q41963641-57871517-2895-48A9-B7A3-E674C0C00B8DQ45324534-A45D1157-0E03-4B22-A25D-13244C2A0CE6Q55341898-50224328-9FF2-4E09-B658-26A7C3E8F1BE
P2860
Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus-related hepatocellular carcinoma.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Multiepitope peptide-loaded vi ...... ated hepatocellular carcinoma.
@en
Multiepitope peptide-loaded vi ...... ated hepatocellular carcinoma.
@nl
type
label
Multiepitope peptide-loaded vi ...... ated hepatocellular carcinoma.
@en
Multiepitope peptide-loaded vi ...... ated hepatocellular carcinoma.
@nl
prefLabel
Multiepitope peptide-loaded vi ...... ated hepatocellular carcinoma.
@en
Multiepitope peptide-loaded vi ...... ated hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Multiepitope peptide-loaded vi ...... ated hepatocellular carcinoma.
@en
P2093
Fei-Xiang Ding
Kai-Hui Wang
Shu-Han Sun
Xiao-Wen He
Yi-Ming Lu
P2860
P304
P356
10.1002/HEP.22816
P407
P577
2009-05-01T00:00:00Z